Progesterone antagonists--pharmacology and perspectives of use
Distler, W.; Vering, A.
Der Gynakologe 25(4): 226-230
1992
ISSN/ISBN: 0017-5994 PMID: 1398251 Document Number: 404291
Document emailed within 1 workday
Related Documents
Anonymous 2000: Progestins, Progesterone Receptor Modulators, and Progesterone Antagonists. Progesterone, progestins and antiprogestins in the next millennium, Jerusalem, Israel, 31 August-3 September, 1999 Steroids 65(10/11): 543-850Spitz, I.M. 2006: Progesterone receptor antagonists Current Opinion in Investigational Drugs 7(10): 882-890
Schunack, W. 1989: Pharmacology of H2-receptor antagonists: an overview Journal of International Medical Research 17(Suppl 1): 9a
Van Nueten, J.M. 1988: Cardiovascular pharmacology of serotonin and its antagonists Revue Medicale de Liege 43(Suppl 1): 22-30
Millar, J.A.; Bramley, P.M. 1984: Clinical pharmacology of calcium antagonists Methods and Findings in Experimental and Clinical Pharmacology 6(4): 205-211
Mills, J.G.; Wood, J.R. 1989: The pharmacology of histamine H2-receptor antagonists Methods and Findings in Experimental and Clinical Pharmacology 11(Suppl 1): 87-95
Mignon, M.; Gislon, J.; Bonfils, S. 1978: Histamine H2 receptor antagonists. Pharmacology and clinical applications La Revue du Praticien 28(53): 4145-4146; 4151-2; 4155-4158
Loo, T.L.; Johns, D.G.; Farquhar, D. 1973: Recent advances in the biochemical pharmacology of folic acid antagonists Transplantation Proceedings 5(3): 1161-1165
Kohno, S. 1996: Molecular pharmacology and application to the bronchial asthma of thromboxane A2 antagonists Nihon Rinsho. Japanese Journal of Clinical Medicine 54(2): 551-558
Takano, Y.; Yaksh, T.L. 1992: Characterization of the pharmacology of intrathecally administered alpha-2 agonists and antagonists in rats Journal of Pharmacology and Experimental Therapeutics 261(2): 764-772
Bouchard, P.; Chabbert-Buffet, N.; Fauser, B.C.J.M. 2011: Selective progesterone receptor modulators in reproductive medicine: pharmacology, clinical efficacy and safety Fertility and Sterility 96(5): 1175-1189
Olivennes, F.; Rongières, C.; Fanchin, R.; Frydman, R. 1998: Perspectives in the use of GnRh antagonists Contraception Fertilite Sexualite 26(3): 187-188
Calam, J. 1993: CCK/gastrin antagonists--clinical perspectives Acta Gastro-Enterologica Belgica 56(3-4): 251-256
De Schaepdryver, A.F. 1992: Clinical pharmacology: current status and perspectives Verhandelingen - Koninklijke Academie Voor Geneeskunde van Belgie 54(1): 7-26
Desquand, S. 1993: Effects of PAF antagonists in experimental models. Therapeutical perspectives Therapie 48(6): 585-597
Epstein, M. 1998: Calcium antagonists and renal protection: emerging perspectives Journal of Hypertension. Supplement: Official Journal of the International Society of Hypertension 16(4): S17-S25
Scarpignato, C.; Bianchi Porro, G. 1985: Cimetropium bromide, a new antispasmodic compound: pharmacology and therapeutic perspectives International Journal of Clinical Pharmacology Research 5(6): 467-477
Gill, R. 1994: The pharmacology of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate antagonists and their role in cerebral ischaemia Cerebrovascular and Brain Metabolism Reviews 6(3): 225-256
Roche, J.F.; Gosling, J.P. 1977: Control of estrus and progesterone levels in heifers given intravaginal progesterone coils and injections of progesterone and estrogen Journal of Animal Science 44(6): 1026-1029
Epstein, M. 1992: Calcium antagonists and renal protection. Current status and future perspectives Archives of Internal Medicine 152(8): 1573-1584